145 related articles for article (PubMed ID: 6605779)
1. Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms.
Silman AJ; Mitchell P; Nicholls RJ; Macrae FA; Leicester RJ; Bartram CI; Simmons MJ; Campbell PD; Hearn CE; Constable PJ
Br J Surg; 1983 Dec; 70(12):721-4. PubMed ID: 6605779
[TBL] [Abstract][Full Text] [Related]
2. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
Thomas WM; Pye G; Hardcastle JD; Mangham CM
Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
[TBL] [Abstract][Full Text] [Related]
3. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
Robinson MH; Marks CG; Farrands PA; Thomas WM; Hardcastle JD
Br J Surg; 1994 Mar; 81(3):448-51. PubMed ID: 8173928
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients.
Pye G; Jackson J; Thomas WM; Hardcastle JD
Br J Surg; 1990 Jun; 77(6):630-1. PubMed ID: 2200550
[TBL] [Abstract][Full Text] [Related]
5. Intervention in large bowel carcinogenesis--does screening improve prognosis?
Farrands PA; Britton DC
Scand J Gastroenterol Suppl; 1984; 104():151-9. PubMed ID: 6597547
[TBL] [Abstract][Full Text] [Related]
6. Faecal occult blood testing in symptomatic patients: comparison of three tests.
Tate JJ; Northway J; Royle GT; Taylor I
Br J Surg; 1990 May; 77(5):523-6. PubMed ID: 2354334
[TBL] [Abstract][Full Text] [Related]
7. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
Hunt LM; Rooney PS; Bostock K; Robinson MH; Hardcastle JD; Armitage NC
Gut; 1997 Jan; 40(1):110-2. PubMed ID: 9155586
[TBL] [Abstract][Full Text] [Related]
8. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
Robinson MH; Kronborg O; Williams CB; Bostock K; Rooney PS; Hunt LM; Hardcastle JD
Br J Surg; 1995 Mar; 82(3):318-20. PubMed ID: 7795994
[TBL] [Abstract][Full Text] [Related]
9. Role of dietary restriction in Haemoccult screening for colorectal cancer.
Thomas WM; Pye G; Hardcastle JD; Chamberlain J; Charnley RM
Br J Surg; 1989 Sep; 76(9):976-8. PubMed ID: 2679967
[TBL] [Abstract][Full Text] [Related]
10. Two-week wait symptoms are prevalent in screened patients with a positive faecal occult blood test but do not predict cancer.
Vaughan-Shaw PG; Cutting J; Borley N; Brooklyn T; Wheeler JM
Colorectal Dis; 2014 Jan; 16(1):40-7. PubMed ID: 24103034
[TBL] [Abstract][Full Text] [Related]
11. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
[TBL] [Abstract][Full Text] [Related]
12. [Screening tests for colon cancer - a new comparison Haemoccult - hemoFEC and review of 9 years clinical experience with Haemoccult (author's transl)].
Gnauck R
Z Gastroenterol; 1982 Feb; 20(2):84-92. PubMed ID: 6977955
[TBL] [Abstract][Full Text] [Related]
13. The incidence of occult bleeding per rectum in a general practice in Scotland: a study using haemoccult.
Lawson AH
Scott Med J; 1982 Jan; 27(1):49-51. PubMed ID: 7063830
[TBL] [Abstract][Full Text] [Related]
14. Experience with haemoccult screening in Hungary. A multicenter trial.
Siba S
Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up.
Robinson MH; Marks CG; Farrands PA; Bostock K; Hardcastle JD
Br J Surg; 1996 Apr; 83(4):500-1. PubMed ID: 8665240
[TBL] [Abstract][Full Text] [Related]
16. Value of a risk questionnaire in screening for colorectal neoplasm.
Kewenter J; Haglind E; Smith L
Br J Surg; 1989 Mar; 76(3):280-3. PubMed ID: 2720326
[TBL] [Abstract][Full Text] [Related]
17. Screening for symptomless colorectal cancer by testing for occult blood in general practice.
Hardcastle JD; Balfour TW; Amar SS
Lancet; 1980 Apr; 1(8172):791-3. PubMed ID: 6102678
[TBL] [Abstract][Full Text] [Related]
18. Dark red bleeding as a marker for large bowel neoplasms: a pilot study.
Silman AJ; Mitchell P; Nicholls RJ; Macrae F; Leicester RJ; Bartram CI; Simmons M; Campbell P; Constable P; Hearn D
Br J Surg; 1985 Sep; 72 Suppl():S72-4. PubMed ID: 3876133
[No Abstract] [Full Text] [Related]
19. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult.
Thomas WM; Pye G; Hardcastle JD; Walker AR
Br J Surg; 1992 Aug; 79(8):833-5. PubMed ID: 1393487
[TBL] [Abstract][Full Text] [Related]
20. Screening for colorectal cancer in a Hungarian county.
Ujszászy L; Prónay G; Nagy G; Kovács J; Libor J; Minik K
Endoscopy; 1985 May; 17(3):109-12. PubMed ID: 4006870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
